摘要
尽管近年来医学生物科技水平不断进步,诊断和治疗水平不断提高,但是肺癌的早期发现,诊断和治疗,以及对于术后是否有复发的预测仍然是有待进一步努力和提高的关键部分。
With the continuous improvement of medical biotechnology in the recent years, the level of diagnosis and treatment of lung cancer has been increasing. But the early detection, diagnosis and treatment of lung cancer, and the predictions of postoperative recurrence are still key parts which need to be improved in future.
出处
《临床医学工程》
2012年第5期836-837,共2页
Clinical Medicine & Engineering
关键词
非小细胞肺癌
基因突变
术后复发
Non-small cell lung cancer
Gene mutation
Postoperative recurrence